Ikena Oncology Inc reports results for the quarter ended in June - Earnings Summary

ImageneBio

12/08/2021 13:55

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss of 35 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 36 cents per share.
* Revenue was $3.55 million​;  analysts expected $3.93 million. 
* Ikena Oncology Inc's reported EPS for the quarter was a loss
of 35 cents​.
* The mean earnings estimate of analysts had fallen by
about 14.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ikena Oncology Inc shares had fallen by 26.9% this quarter.
* The company reported a quarterly loss of $12.68 million.
* Wall Street's median 12-month price target for Ikena Oncology
Inc is $28.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 12:55 p.m.  ​All
figures in US dollars unless otherwise stated